Alto Ingredients vs Ingevity
Ingevity is the larger business, with $1.17bn of revenue in fiscal 2025 against $918m for Alto Ingredients (1.3 times as much). Ingevity grew faster (-2.7% against -4.9%). Alto Ingredients kept more of each dollar of sales as profit: a net margin of 1.5% against -14.3%.
| Latest fiscal year | Alto IngredientsALTO, 2025 | IngevityNGVT, 2025 |
|---|---|---|
| Revenue | $918m | $1.17bn |
| Revenue growth | -4.9% | -2.7% |
| Net income | $13.3m | −$167m |
| Operating margin | — | 35.9% |
| Net margin | 1.5% | -14.3% |
| Return on equity | 5.7% | -148.6% |
| Free cash flow | $8.6m | $274m |
| Cash | $23.4m | $78.1m |
| Total debt | $84.6m | $1.21bn |
| Debt to equity | — | 4079.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $56.3m |
| Employees | 390 | 1,500 |
| Market value | $275m | $2.55bn |
| Price vs our value range | Within our value range | Above our value range |
| Moat score | 34 (Weak) | 74 (Strong) |
| Insider trades, 12 months | 4 buys, 0 sales | 0 buys, 10 sales |